Pasithea Therapeutics (KTTA) Other financing activities (2021 - 2025)
Pasithea Therapeutics recorded quarterly Other financing activities of $39310.0 in Q4 2025, down 66.15% quarter-over-quarter from $116145.0 in Q3 2025, and up 108.59% year-over-year from $18845.5 in Q4 2024.
Pasithea Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $39310.0 for Q4 2025.
- In Q4 2025, Other financing activities rose 108.59% year-over-year to $39310.0; the TTM figure through Dec 2025 stood at $448279.0 (up 209.47% YoY), while the FY2025 annual figure was $448279.0, changed N/A from the prior year.
- Other financing activities came in at $39310.0 for Q4 2025 at Pasithea Therapeutics, down from $116145.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $299665.0 in Q2 2021 to a low of -$836150.0 in Q4 2021.
- A 5-year average of -$30604.7 and a median of $24175.0 in 2022 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities slumped 92.02% in 2022 and soared 108.59% in 2025, its largest moves.
- Pasithea Therapeutics' Other financing activities stood at -$836150.0 in 2021, then soared by 91.07% to -$74627.0 in 2022, then jumped by 132.39% to $24175.0 in 2023, then plunged by 1992.86% to -$457600.0 in 2024, then jumped by 108.59% to $39310.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $39310.0, $116145.0, and $113514.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39,310.00 |
| Dec 31, 2025 | 39,310.00 |
| Sep 30, 2025 | 116,145.00 |
| Sep 30, 2025 | 116,145.00 |
| Jun 30, 2025 | 113,514.00 |
| Jun 30, 2025 | 113,514.00 |
| Mar 31, 2025 | 179,310.00 |
| Mar 31, 2025 | 179,310.00 |
| Dec 31, 2024 | -457,600.00 |
| Dec 31, 2024 | -457,600.00 |
| Sep 30, 2023 | 24,175.00 |
| Sep 30, 2023 | 24,175.00 |
| Jun 30, 2023 | 23,912.00 |
| Jun 30, 2023 | 23,912.00 |
| Mar 31, 2023 | 23,649.00 |
| Mar 31, 2023 | 23,649.00 |
| Dec 31, 2022 | -74,627.00 |
| Dec 31, 2022 | -74,627.00 |
| Sep 30, 2022 | 24,175.00 |
| Sep 30, 2022 | 24,175.00 |
| Jun 30, 2022 | 23,912.00 |
| Jun 30, 2022 | 23,912.00 |
| Mar 31, 2022 | 26,540.00 |
| Mar 31, 2022 | 26,540.00 |
| Dec 31, 2021 | -836,150.00 |
| Dec 31, 2021 | -836,150.00 |
| Sep 30, 2021 | 15,000.00 |
| Sep 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 299,665.00 |
| Jun 30, 2021 | 299,665.00 |